Publication | Closed Access

Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines

VaccinationVaccine SafetyVaccine DevelopmentMedicineImmunologyVaccine TestingHpv VaccinesInfection ControlPolyvalent VaccinePrecision VaccinologyVaccine Research